3Ross R. Atherosclerosis : an inflammatory disease [ J ]. N Engl J Med, 1999,340(2) : 115 - 126.
4Libby P. Inflammation in atherosclerosis [ J ]. Nature, 2002,420 (6917) :868 -874.
5Papaspyridonos M, McNeill E, de Bono ]P, Smith A, Burnantd KG, Channon KM, Greaves DR. Galectin - 3 is an amplifier of in- flammation in atherosclerotic plaque progression through macro- phage activation and monocyte chemoattraction [ J 1. Arterioscler Thromb Vasc Biol,2008,28(3 ):433 -440.
6Hu CL, Xiang JZ, Hu FF, Huang CX. Adventitial inflammation: a possible pathogenic link to the instability of atherosclerotic plaque [ J ]. Med Hypotheses ,2007,68(6) : 1262 - 1264.
7de Boer U J, Teeling P, ldu MM, Hecker AE, van der Wal AC. Epstein Barr virus specific T - cells generated from unstable human atherosclerotic lesions: Implications for plaque inflammation [ J ]. Atherosclerosis,2006,184 ( 2 ) :322 - 329.
8Shiner M, Fuhrman B, Aviram M. Macrophage paraoxonase 2 ( PON2 ) expression is up - regulated by pomegranate juice phenol- ic anti - oxidants via PPAR gamma and AP - 1 pathway activation [J]. Atherosclerosis,2007,195(2) :313 -321.
9Mullenix PS, Audersen CA, Starnes BW. Atherosclerosis as inflam- mation [ J ]. Ann VascSurg,2005,19 ( 1 ) : 130 - 138.
10Papaspyridonos M, McNeill E, Greaves DR et al. Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction[J]. Arterioscler Thromb Vasc Biol, 2008,28 (3) : 433-440.
